Expression of hepatitis C virus hypervariable region 1 and its clinical significance.

about

Expression of hepatitis C virus hypervariable region 1 and its clinical significance.

Item

http://www.wikidata.org/entity/Q36178437

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Expression of hepatitis C virus hypervariable region 1 and its clinical significance.

@ast

Expression of hepatitis C virus hypervariable region 1 and its clinical significance.

@en

type

Item

label

Expression of hepatitis C virus hypervariable region 1 and its clinical significance.

@ast

Expression of hepatitis C virus hypervariable region 1 and its clinical significance.

@en

prefLabel

Expression of hepatitis C virus hypervariable region 1 and its clinical significance.

@ast

Expression of hepatitis C virus hypervariable region 1 and its clinical significance.

@en

P1476

Expression of hepatitis C virus hypervariable region 1 and its clinical significance

@en

P2093

Jing Liu

http://www.w3.org/2001/XMLSchema#string

Shen-Ying Zhang

http://www.w3.org/2001/XMLSchema#string

Xin-Xin Zhang

http://www.w3.org/2001/XMLSchema#string

Yuan Wang

http://www.w3.org/2001/XMLSchema#string

Zhi-Meng Lu

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapy.

Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome

Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients

Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution

Antibody responses to the hepatitis C virus E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects.

Vaccination of chimpanzees against infection by the hepatitis C virus

Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections

HCV replication in PBMC and its influence on interferon therapy

Combination of "low-dose" ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic HCV-infected non-responders and relapsers after interferon alfa-2a monotherapy

Factors predictive of a beneficial response to therapy of hepatitis C.

P304

1003-1007

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V9.I5.1003

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2003-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12717846

http://www.w3.org/2001/XMLSchema#string

P932

4611362

http://www.w3.org/2001/XMLSchema#string